Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

DOI Full Paper Access

518

Citations

24

References

2021

Year

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis, Georgios Adamis, Konstantinos Tsiakos, Archontoula Fragkou, Aggeliki Rapti, Christina Damoulari, Massimo Fantoni, Ioannis Kalomenidis,

Nature Medicine

References

	Year	Citations

Page 1